Zinc (Zn2⁺) and copper (Cu2⁺) are the second and third most abundant transition metals in the human body, and their dysregulation is associated with various pathological conditions, necessitating sensitive and selective detection strategies. Fluorescence-based sensing is particularly attractive due to its high sensitivity, simplicity, and biocompatibility. Herein, we report a series of hydrazone-linked Schiff base chemosensors incorporating pyrene (L1), anthracene (L2), and triphenylamine (L3) moieties. These probes exhibit distinct colorimetric responses toward Zn2⁺/Cu2⁺ and a selective fluorescence “turn-on” response toward Zn2⁺ in DMSO–HEPES buffer (1:1, v/v, pH 7.4), with negligible interference from competing metal ions. The fluorescence enhancement originates from Zn2⁺-induced chelation-enhanced fluorescence (CHEF) accompanied by suppression of PET and C = N isomerization. Job’s plot and spectroscopic analyses indicate a 2:1 ligand-to-metal binding stoichiometry, corroborated by HRMS, 1HNMR titrations and DFT calculations. The sensors display moderate to strong binding affinities (Ka = 3.5–25.8 × 105 M⁻1) and micromolar (µM) detection limits for Zn2⁺ and Cu2+ ions. Combined spectroscopic and computational studies establish clear structure–property relationships, while reversibility experiments confirm the robustness and reusability of these probes.
No takes yet. Share an insight, caveat, or question.
Aditya et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: